Moreover, a retrospective case-control study revealed that several factors, including advanced age, menopause, weight loss, cyst diameter equal to or exceeding 8.33cm, and the presence of solid areas on ultrasonography, were identified as noteworthy risk factors for EAOC (123)
Over time, clinical trials run by Novo Nordisk and Eli Lilly showed that patients not only improved their blood sugar control but also experienced significant weight loss
Typically, insurance coverage for Mounjaro is reserved for individuals with confirmed type 2 diabetes diagnoses, as it's not traditionally approved for weight loss purposes
This usually happens during dose escalation and often settles as the body adjusts
At Cymbiotika, we believe that understanding your bodys natural signals is the first step toward true wellness